Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch) released the «Global Rosuvastatin Market Segment Research Report 2022», which aims to sort out the development status and trends of the Rosuvastatin industry at home and abroad, estimate the overall market scale of the Rosuvastatin industry and the market share of major countries, analyze the development potential of each segment of the Rosuvastatin industry, and study and judge the downstream market demand of Rosuvastatin through systematic research, Analyze the competition pattern of Rosuvastatin, so as to help solve the pain points of various stakeholders in Rosuvastatin industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Rosuvastatin Market by XYZResearch Include
- USA
- Europe
- China
- Japan
- India
- Korea
- Southeast Asia
Competitive Analysis; Who are the Major Players in Rosuvastatin Market?
- AstraZeneca
- Teva Pharmaceutical Industries
- MSN Laboratories
- Cadila Pharmaceuticals
- LGM Pharma
- Bal Pharma
- Changzhou Pharmaceutical Factory
- Jingxin Pharm
- Zhejiang Hisun Pharmaceutical
- HEC Pharm
- Lunan Pharmaceutical
- Nanjing Frochem Tech
- Lianyungang Runzhong Pharmaceutical
- Shandong Bechem Chemicals
- CTX Life Sciences
Major Type of Rosuvastatin Covered in XYZResearch report:
- Purity 98.0%
- Purity 99.0%
- Other
Application Segments Covered in XYZResearch Market
- Tablet
- Capsule
- Others
For any other requirements, please feel free to contact us and we will provide you customized report.
(Post-pandemic Era) - Global Rosuvastatin Market Segment Research Report 2022
Table of Contents
Global Rosuvastatin Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Rosuvastatin Market by Value
2.2.1 Global Rosuvastatin Revenue by Type
2.2.2 Global Rosuvastatin Market by Value (%)
2.3 Global Rosuvastatin Market by Production
2.3.1 Global Rosuvastatin Production by Type
2.3.2 Global Rosuvastatin Market by Production (%)
3. The Major Driver of Rosuvastatin Industry
3.1 Historical & Forecast Global Rosuvastatin Demand
3.2 Largest Application for Rosuvastatin (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Rosuvastatin Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Rosuvastatin Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Rosuvastatin Production, Demand (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Rosuvastatin Production, Demand (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Rosuvastatin Production, Demand (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Rosuvastatin Production, Demand (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Rosuvastatin Production, Demand (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Rosuvastatin Production, Demand (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Rosuvastatin Production, Demand (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Rosuvastatin Average Price Trend
12.1 Market Price for Each Type of Rosuvastatin in US (2018-2022)
12.2 Market Price for Each Type of Rosuvastatin in Europe (2018-2022)
12.3 Market Price for Each Type of Rosuvastatin in China (2018-2022)
12.4 Market Price for Each Type of Rosuvastatin in Japan (2018-2022)
12.5 Market Price for Each Type of Rosuvastatin in India (2018-2022)
12.6 Market Price for Each Type of Rosuvastatin in Korea (2018-2022)
12.7 Market Price for Each Type of Rosuvastatin in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Rosuvastatin Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Rosuvastatin
14. Rosuvastatin Competitive Landscape
14.1 AstraZeneca
14.1.1 AstraZeneca Company Profiles
14.1.2 AstraZeneca Product Introduction
14.1.3 AstraZeneca Rosuvastatin Sales, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Teva Pharmaceutical Industries
14.2.1 Teva Pharmaceutical Industries Company Profiles
14.2.2 Teva Pharmaceutical Industries Product Introduction
14.2.3 Teva Pharmaceutical Industries Rosuvastatin Sales, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 MSN Laboratories
14.3.1 MSN Laboratories Company Profiles
14.3.2 MSN Laboratories Product Introduction
14.3.3 MSN Laboratories Rosuvastatin Sales, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Cadila Pharmaceuticals
14.4.1 Cadila Pharmaceuticals Company Profiles
14.4.2 Cadila Pharmaceuticals Product Introduction
14.4.3 Cadila Pharmaceuticals Rosuvastatin Sales, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 LGM Pharma
14.5.1 LGM Pharma Company Profiles
14.5.2 LGM Pharma Product Introduction
14.5.3 LGM Pharma Rosuvastatin Sales, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Bal Pharma
14.6.1 Bal Pharma Company Profiles
14.6.2 Bal Pharma Product Introduction
14.6.3 Bal Pharma Rosuvastatin Sales, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Changzhou Pharmaceutical Factory
14.7.1 Changzhou Pharmaceutical Factory Company Profiles
14.7.2 Changzhou Pharmaceutical Factory Product Introduction
14.7.3 Changzhou Pharmaceutical Factory Rosuvastatin Sales, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Jingxin Pharm
14.8.1 Jingxin Pharm Company Profiles
14.8.2 Jingxin Pharm Product Introduction
14.8.3 Jingxin Pharm Rosuvastatin Sales, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Zhejiang Hisun Pharmaceutical
14.9.1 Zhejiang Hisun Pharmaceutical Company Profiles
14.9.2 Zhejiang Hisun Pharmaceutical Product Introduction
14.9.3 Zhejiang Hisun Pharmaceutical Rosuvastatin Sales, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 HEC Pharm
14.10.1 HEC Pharm Company Profiles
14.10.2 HEC Pharm Product Introduction
14.10.3 HEC Pharm Rosuvastatin Sales, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Lunan Pharmaceutical
14.12 Nanjing Frochem Tech
14.13 Lianyungang Runzhong Pharmaceutical
14.14 Shandong Bechem Chemicals
14.15 CTX Life Sciences
15. Conclusion
List of Tables and Figures
Figure 1. Total Demand by Application of Rosuvastatin Industry (Volume)
Figure 2. Rosuvastatin Production & Demand by Regions in 2021
Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
Figure 4. The Top 10 and 5 Players Market Share by Rosuvastatin Revenue in 2021
Figure 5. US Rosuvastatin Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Rosuvastatin Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Rosuvastatin Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Rosuvastatin Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Rosuvastatin Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Rosuvastatin Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Rosuvastatin Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Rosuvastatin Revenue, by Type (Million USD) (2018-2028)
Table 4. Rosuvastatin Production, by Type (K Unit) (2018-2028)
Table 5. Rosuvastatin Demand (K Unit) by Application (2018-2028)
Table 6. Rosuvastatin Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2021)
Table 9. Regional Market Share in Terms of Revenue (2021&2027)
Table 10. Ranking of Global Top Rosuvastatin Companies by Revenue, Concentration Ratio in 2021
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Rosuvastatin Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Rosuvastatin Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Rosuvastatin Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Rosuvastatin Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Rosuvastatin Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Rosuvastatin Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Rosuvastatin Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Rosuvastatin in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Rosuvastatin in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Rosuvastatin in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Rosuvastatin in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Rosuvastatin in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Rosuvastatin in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Rosuvastatin in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. AstraZeneca Profiles
Table 61. AstraZeneca Rosuvastatin Product Introduction
Table 62. AstraZeneca Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. AstraZeneca Strategic initiatives
Table 64. Teva Pharmaceutical Industries Profiles
Table 65. Teva Pharmaceutical Industries Rosuvastatin Product Introduction
Table 66. Teva Pharmaceutical Industries Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Teva Pharmaceutical Industries Strategic initiatives
Table 68. MSN Laboratories Profiles
Table 69. MSN Laboratories Rosuvastatin Product Introduction
Table 70. MSN Laboratories Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. MSN Laboratories Strategic initiatives
Table 72. Cadila Pharmaceuticals Profiles
Table 73. Cadila Pharmaceuticals Rosuvastatin Product Introduction
Table 74. Cadila Pharmaceuticals Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Cadila Pharmaceuticals Strategic initiatives
Table 76. LGM Pharma Profiles
Table 77. LGM Pharma Rosuvastatin Product Introduction
Table 78. LGM Pharma Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. LGM Pharma Strategic initiatives
Table 80. Bal Pharma Profiles
Table 81. Bal Pharma Rosuvastatin Product Introduction
Table 82. Bal Pharma Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Bal Pharma Strategic initiatives
Table 84. Changzhou Pharmaceutical Factory Profiles
Table 85. Changzhou Pharmaceutical Factory Rosuvastatin Product Introduction
Table 86. Changzhou Pharmaceutical Factory Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Changzhou Pharmaceutical Factory Strategic initiatives
Table 88. Jingxin Pharm Profiles
Table 89. Jingxin Pharm Rosuvastatin Product Introduction
Table 90. Jingxin Pharm Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Jingxin Pharm Strategic initiatives
Table 92. Zhejiang Hisun Pharmaceutical Profiles
Table 93. Zhejiang Hisun Pharmaceutical Rosuvastatin Product Introduction
Table 94. Zhejiang Hisun Pharmaceutical Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Zhejiang Hisun Pharmaceutical Strategic initiatives
Table 97. HEC Pharm Profiles
Table 98. HEC Pharm Rosuvastatin Product Introduction
Table 99. HEC Pharm Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. HEC Pharm Strategic initiatives
Table 101. Lunan Pharmaceutical Profiles
Table 102. Lunan Pharmaceutical Rosuvastatin Product Introduction
Table 103. Lunan Pharmaceutical Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Lunan Pharmaceutical Strategic initiatives
Table 105. Nanjing Frochem Tech Profiles
Table 106. Nanjing Frochem Tech Rosuvastatin Product Introduction
Table 107. Nanjing Frochem Tech Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. Nanjing Frochem Tech Strategic initiatives
Table 109. Lianyungang Runzhong Pharmaceutical Profiles
Table 110. Lianyungang Runzhong Pharmaceutical Rosuvastatin Product Introduction
Table 111. Lianyungang Runzhong Pharmaceutical Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Table 112. Lianyungang Runzhong Pharmaceutical Strategic initiatives
Table 113. Shandong Bechem Chemicals Profiles
Table 114. Shandong Bechem Chemicals Rosuvastatin Product Introduction
Table 115. Shandong Bechem Chemicals Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Table 116. Shandong Bechem Chemicals Strategic initiatives
Table 117. CTX Life Sciences Profiles
Table 118. CTX Life Sciences Rosuvastatin Product Introduction
Table 119. CTX Life Sciences Rosuvastatin Sales (Unit), Revenue (Million USD) (2018-2022)
Global Digoxin Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 75
According to our LPI (LP Information) latest study, the global Digoxin market size was valued at US$ 59 million in 2023. With growing demand in downstream market, the Digoxin is forecast to a readjusted size of US$ 73 million by 2030 with a CAGR of 3.2% during review period.
The research report highlights the growth potential of the global Digoxin market. Digoxin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain op......
Global Heart Failure Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 116
According to our LPI (LP Information) latest study, the global Heart Failure Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Heart Failure Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Heart Failure Drugs market. Heart Failure Drugs are expected to show stable growth in the future market. However, product differentiatio......
Global Atorvastatin Calcium Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 138
According to our LPI (LP Information) latest study, the global Atorvastatin Calcium market size was valued at US$ 214.2 million in 2023. With growing demand in downstream market, the Atorvastatin Calcium is forecast to a readjusted size of US$ 362 million by 2030 with a CAGR of 7.8% during review period.
The research report highlights the growth potential of the global Atorvastatin Calcium market. Atorvastatin Calcium are expected to show stable growth in the future market. However, prod......
Global Rosuvastatin Calcium Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 139
According to our LPI (LP Information) latest study, the global Rosuvastatin Calcium market size was valued at US$ 514.3 million in 2023. With growing demand in downstream market, the Rosuvastatin Calcium is forecast to a readjusted size of US$ 683.6 million by 2030 with a CAGR of 4.1% during review period.
The research report highlights the growth potential of the global Rosuvastatin Calcium market. Rosuvastatin Calcium are expected to show stable growth in the future market. However, pr......
Global Atorvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 133
According to our (Global Info Research) latest study, the global Atorvastatin Calcium market size was valued at USD 225.3 million in 2023 and is forecast to a readjusted size of USD 366.1 million by 2030 with a CAGR of 7.2% during review period.
Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL choleste......
Global Rosuvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 132
According to our (Global Info Research) latest study, the global Rosuvastatin Calcium market size was valued at USD 540.9 million in 2023 and is forecast to a readjusted size of USD 703.6 million by 2030 with a CAGR of 3.8% during review period.
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart att......
Cilostazol - Global Market Insights and Sales Trends 2024
Published: 25-Dec-2023 Price: US 3350 Onwards Pages: 118
The global Cilostazol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cilostazol in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Cilostazol market. Injection Cilostazol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-dried P......
Rosuvastatin - Global Market Insights and Sales Trends 2024
Published: 25-Dec-2023 Price: US 3350 Onwards Pages: 110
Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well.
The global Rosuvastatin market size is expected......
Global Congestive Heart Failure Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 19-Dec-2023 Price: US 3380 Onwards Pages: 123
Market Overview of Global Congestive Heart Failure Drugs market:
According to our latest research, the global Congestive Heart Failure Drugs market looks promising in the next 5 years. As of 2022, the global Congestive Heart Failure Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Congestive heart failure is a serious and complex condition in which the heart muscles are either dam......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
